Condition
Malignant Mesothelioma
Estimated Enrollment: 46
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: CALGB-30601|U10CA031946|CDR0000558362
Study First Received: July 30, 2007
Last Updated: July 11, 2016
Estimated Primary Completion Date: February 2010
Primary Outcome Measures:
24 Week Progression Free Survival|Number of Participants With Overall Tumor Response|Overall Survival|Progression Free Survival
Sponsors and Collaborators:
Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00509041
